197 related articles for article (PubMed ID: 18948835)
1. Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?
Kaczmarek P; Malendowicz LK; Fabis M; Ziolkowska A; Pruszynska-Oszmalek E; Sassek M; Wojciechowicz T; Szczepankiewicz D; Andralojc K; Szkudelski T; Strowski MZ; Nowak KW
Pancreas; 2009 Mar; 38(2):208-12. PubMed ID: 18948835
[TBL] [Abstract][Full Text] [Related]
2. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets.
Kaczmarek P; Malendowicz LK; Pruszynska-Oszmalek E; Wojciechowicz T; Szczepankiewicz D; Szkudelski T; Nowak KW
Int J Mol Med; 2006 Nov; 18(5):951-5. PubMed ID: 17016626
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin U Does Not Act as a Decretin in Rats.
Kuhre RE; Christiansen CB; Ghiasi SM; Gabe MBN; Skat-Rørdam PA; Modvig IM; Mandrup-Poulsen T; Albrechtsen R; Rosenkilde MM; Hartmann B; Wewer Albrechtsen NJ; Holst JJ
Cell Metab; 2019 Mar; 29(3):719-726.e5. PubMed ID: 30449683
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.
Zhang W; Sakoda H; Nakazato Y; Islam MN; Pattou F; Kerr-Conte J; Nakazato M
PLoS One; 2021; 16(4):e0250232. PubMed ID: 33857254
[TBL] [Abstract][Full Text] [Related]
5. Neuromedin U suppresses glucose-stimulated insulin secretion in pancreatic β cells.
Zhang W; Sakoda H; Miura A; Shimizu K; Mori K; Miyazato M; Takayama K; Hayashi Y; Nakazato M
Biochem Biophys Res Commun; 2017 Nov; 493(1):677-683. PubMed ID: 28864416
[TBL] [Abstract][Full Text] [Related]
6. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
7. Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic β-cells.
Zhang W; Sakoda H; Nakazato M
FASEB J; 2020 Jan; 34(1):133-147. PubMed ID: 31914613
[TBL] [Abstract][Full Text] [Related]
8. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression patterns of neuromedin U and its receptors in pigs.
Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
[TBL] [Abstract][Full Text] [Related]
11. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas.
Silvestre RA; Egido EM; Hernández R; Marco J
J Endocrinol; 2008 Feb; 196(2):283-90. PubMed ID: 18252951
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
[TBL] [Abstract][Full Text] [Related]
14. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
15. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.
Rucinski M; Ziolkowska A; Tyczewska M; Szyszka M; Malendowicz LK
Int J Mol Med; 2008 Sep; 22(3):363-8. PubMed ID: 18698496
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glucose tolerance between wild-type mice and mice with double knockout of neuromedin U and neuromedin S.
Ensho T; Maruyama K; Qattali AW; Yasuda M; Uemura R; Murakami N; Nakahara K
J Vet Med Sci; 2019 Sep; 81(9):1305-1312. PubMed ID: 31341114
[TBL] [Abstract][Full Text] [Related]
17. Stimulus-specific inhibition of insulin release from rat pancreas by both rat and porcine galanin.
Verchere CB; Kwok YN; Brown JC
Life Sci; 1992; 51(25):1945-51. PubMed ID: 1280755
[TBL] [Abstract][Full Text] [Related]
18. Neuromedin U inhibits food intake partly by inhibiting gastric emptying.
Dalbøge LS; Pedersen SL; Secher T; Holst B; Vrang N; Jelsing J
Peptides; 2015 Jul; 69():56-65. PubMed ID: 25895852
[TBL] [Abstract][Full Text] [Related]
19. The effect of intraislet somatostatin immunoneutralization on insulin secretion in the isolated perfused rat pancreas.
Brunicardi FC; Wen D; Bradley JC; Elahi D; Miller C; Hanks J
Int J Surg Investig; 2000; 1(5):381-8. PubMed ID: 11341594
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model.
Tirone TA; Norman MA; Moldovan S; DeMayo FJ; Wang XP; Brunicardi FC
Pancreas; 2003 Apr; 26(3):e67-73. PubMed ID: 12657967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
